Skip to content

Feasibility study for the development of a digital decision aid to support medication discontinuation

Feasibility study for the development of a digital decision aid to support medication discontinuation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00039277
Enrollment
10
Registered
2026-02-13
Start date
2026-02-03
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The present study does not investigate a disease

Interventions

Group 1: Over a six-week period, primary care physicians counsel three to four patients using the further developed digital decision aid arribaMediQuit. Afterwards, they provide feedback on their expe

Sponsors

Marburger Institut für Allgemeinmedizin
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: General practitioner in active practice in central and northern Hesse

Exclusion criteria

Exclusion criteria: Lack of a computer in the consultation room

Design outcomes

Primary

MeasureTime frame
The aim of the study is to obtain initial insights into how the counseling tool is used by general practitioners in everyday clinical practice. Specifically, the study explores which medication groups MediQuit is most frequently used for; in which situations and at what point in the clinical workflow the tool is opened and applied; how long the tool is used during a counseling session; and which functions (e.g., visualizations, tapering plans) are used most often. In addition, the study examines how general practitioners assess the usefulness of the tool for structuring consultations on the topic of medication discontinuation. Furthermore, it investigates in which cases the tool is used to support communication with patients, and when it is used primarily as a reference resource for physicians, or for educational purposes. Finally, the study assesses whether the tool’s recommendations regarding medication discontinuation or continuation align with general practitioners’ clinical judgment, including consideration of patients’ preferences

Secondary

MeasureTime frame
The results of the study will inform the further development of the counseling tool and provide the basis for planning subsequent studies, such as a randomized controlled trial or an implementation study.

Countries

Germany

Contacts

Public ContactNele Kornder

Marburger Institut für Allgemeinmedizin

nele.kornder@uni-marburg.de+49 6421 28-65121

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Sep 19, 2026